Skip to content

TAS Medical

2 viewers · 30d

Total raised

$3.9M

+$3.9M this year

1 filing since 2026 · latest Equity filed

Cumulative raised
LAST ROUND
Equity · $3.9M
ROUNDS
1
INVESTORS
17
FOUNDED
N/A
HQ
Windermere, FL
SECTOR
Healthcare
EMPLOYEES
N/A
30D VIEWERS
2

AI overview

Updated

TAS Medical is a Windermere, Florida medical device company that has developed the Trans Abdominal Strap (TAS), a tissue approximation system for closing abdominal wall defects. Instead of sutures, the system uses implantable surgical-grade zip straps to approximate tissue and produce a full-thickness fascial closure through a laparoscopic port. The company's aim is to make ventral hernia repairs reproducible enough to be done minimally invasively rather than open, and to reduce reliance on surgical mesh. It was founded in 2017 by Michael Tozzi, Albert K. Chin and Thomas A. Kramer, and holds a portfolio of US patents issued between 2015 and 2024.

What sets it apart

A zip-strap implant that delivers reproducible full-thickness abdominal wall closure through the narrow working channel of laparoscopic surgery - the step that today forces most ventral hernia repairs to be done open, or to leave the defect bridged by a large piece of mesh.

Funding history

1 round
Equity+2Mar 27, 2026
Form D
+$3.9M$3.9M total

Latest SEC filings

via EDGAR · CIK 0001739794
Form D · Mar 27, 2026View on EDGAR

Products

1 tracked

Trans Abdominal Strap (TAS)

Surgical implant / tissue approximation device

An implantable medical-grade zip strap and delivery system that approximates tissue and closes hernia defects and surgical incisions, used in laparoscopic and robotic ventral hernia repair as a replacement for suture-based fascial closure.

  • Implantable surgical-grade zip strap rather than sutures
  • Full-thickness abdominal wall closure through a laparoscopic working channel
  • Applicable to minimally invasive and robotic surgery
  • Designed to remove the need for a bridging mesh